Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can a 'flawless' live vector vaccine strain be engineered?

J E Galen1, M M Levine

  • 1Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St, Baltimore, MD 21201, USA. jgalen@medicine.umaryland.edu

Trends in Microbiology
|August 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in the development of Salmonella-based vaccine strategies for protection against Salmonellosis in humans.

Journal of applied microbiology·2021
Same author

Factors associated with typical enteropathogenic <i>Escherichia coli</i> infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012.

Epidemiology and infection·2020
Same author

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Vaccine·2019
Same author

Diarrhoea, enteric pathogen detection and nutritional indicators among controls in the Global Enteric Multicenter Study, Kenya site: an opportunity to understand reference populations in case-control studies of diarrhoea.

Epidemiology and infection·2018
Same author

Overexpression of O-polysaccharide chain length regulators in Gram-negative bacteria using the Wzx-/Wzy-dependent pathway enhances production of defined modal length O-polysaccharide polymers for use as haptens in glycoconjugate vaccines.

Journal of applied microbiology·2018
Same author

Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activity.

Lipids·2016

Live bacterial vector vaccines require sufficient antigen presentation for efficacy. Minimizing metabolic burden enhances vector fitness and improves immune responses to foreign antigens.

Area of Science:

  • * Microbiology and Immunology
  • * Vaccine Development
  • * Bacterial Vector Systems

Background:

  • * Live bacterial vector vaccines rely on effective foreign antigen presentation for immune stimulation.
  • * High-level antigen synthesis can impose metabolic load, reducing vector fitness and vaccine efficacy.
  • * This metabolic burden can diminish immune responses to both the vector and the target antigen.

Purpose of the Study:

  • * To investigate the mechanisms underlying metabolic load in live bacterial vector vaccines.
  • * To propose strategies for mitigating metabolic burden.
  • * To enhance the fitness and immunogenicity of Salmonella-based vector vaccines.

Main Methods:

  • * Exploration of metabolic pathways affected by heterologous antigen expression.

Related Experiment Videos

  • * Analysis of vector fitness under varying antigen expression levels.
  • * Assessment of immune responses elicited by modified vector systems.

    • Main Results:

    • * Identified key metabolic bottlenecks associated with high-level antigen synthesis.
    • * Demonstrated that reducing metabolic burden improves bacterial vector fitness.
    • * Showcased enhanced immunogenicity of Salmonella vectors with optimized antigen expression.

    Conclusions:

    • * Metabolic load is a critical factor limiting the efficacy of live bacterial vector vaccines.
    • * Strategies to minimize metabolic burden are essential for improving vaccine performance.
    • * Optimized Salmonella-based vector vaccines show promise for enhanced protective immunity.